Short Communication| Volume 312, ISSUE 1-2, P173-176, January 15, 2012

Download started.


Guillain–Barré syndrome associated with the D222E variant of the 2009 pandemic influenza A (H1N1) virus: Case report and review of the literature

Published:October 14, 2011DOI:


      Guillain–Barré syndrome (GBS) is an acute immune-mediated disorder of the peripheral nervous system and a triggering infectious event is often reported in the weeks before the disease onset. Influenza viruses have been associated with Guillain–Barré syndrome (GBS), both after infection and, in rare cases, after vaccination. However, GBS has rarely reported to be a neurological complication of the recent pandemic influenza A(H1N1) 2009 virus infections. Here we describe the case of a young man, who developed acute severe motor inflammatory demyelinating polyradiculoneuropathy during influenza A(H1N1)2009 infection. Peculiar features are the findings of a mutated haemagglutinin gene (D222E variant), which has never previously been associated with neurological involvement, and the almost simultaneous appearance of respiratory infectious and immune-mediated neurological symptoms. Moreover we review the clinical presentation, laboratory findings and outcome of influenza-related GBS.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Hughes R.A.
        • Cornblath D.R.
        Guillain–Barré syndrome.
        Lancet. 2005 Nov 5; 366: 1653-1666
        • Lehmann H.C.
        • Hartung H.P.
        • Kieseier B.C.
        • Hughes R.A.
        Guillain–Barré syndrome after exposure to influenza virus.
        Lancet Infect Dis. 2010 Sep; 10: 643-651
        • Alfonsi E.
        • Merlo I.M.
        • Clerici A.M.
        • Candeloro E.
        • Marchioni E.
        • Moglia A.
        Proximal nerve conduction by high-voltage electrical stimulation in S1 radiculopathies and acquired demyelinating neuropathies.
        Clin Neurophysiol. 2003 Feb; 114: 239-247
        • Jacobs B.C.
        • Rothbarth P.H.
        • van der Meché F.G.
        • Herbrink P.
        • Schmitz P.I.
        • de Klerk M.A.
        • et al.
        The spectrum of antecedent infections in Guillain–Barré syndrome: a case-control study.
        Neurology. 1998; 51: 1110-1115
        • Guillain–Barré Syndrome Study Group
        Guillain–Barré syndrome: an Italian multicentre casecontrol study. Guillain–Barré Syndrome Study Group.
        Neurol Sci. 2000; 21: 229-234
        • Tam C.C.
        • O'Brien S.J.
        • Petersen I.
        • Islam A.
        • Hayward A.
        • Rodrigues L.C.
        Guillain–Barré syndrome and preceding infection with campylobacter, influenza and Epstein–Barr virus in the general practice research database.
        PLoS One. 2007 Apr 4; 2: e344
        • Stowe J.
        • Andrews N.
        • Wise L.
        • Miller E.
        Investigation of the temporal association of Guillain–Barre syndrome with influenza vaccine and influenzalike illness using the United Kingdom General Practice Research Database.
        Am J Epidemiol. 2009 Feb 1; 169: 382-388
        • Sivadon-Tardy V.
        • Orlikowski D.
        • Porcher R.
        • Sharshar T.
        • Durand M.C.
        • Enouf V.
        • et al.
        Guillain–Barré syndrome and influenza virus infection.
        Clin Infect Dis. 2009; 48: 48-56
        • Cosi V.
        • Versino M.
        Guillain–Barré syndrome.
        Neurol Sci. 2006 Mar; 27: S47-S51
        • Simpson B.S.
        • Rajabally Y.A.
        Sensori-motor Guillain–Barré syndrome with anti-GD1b antibodies following influenza A infection.
        Eur J Neurol. 2009 Apr; 16: e81
        • Chaari A.
        • Bahloul M.
        • Dammak H.
        • Nourhene G.
        • Rekik N.
        • Hedi C.
        • et al.
        Guillain–Barré syndrome related to pandemic influenza A (H1N1) infection.
        Intensive Care Med. 2010 Jul; 36: 1275
        • Kutlesa M.
        • Santini M.
        • Krajinović V.
        • Raffanelli D.
        • Barsić B.
        Acute motor axonal neuropathy associated with pandemic H1N1 influenza A infection.
        Neurocrit Care. 2010 Aug; 13: 98-100
        • Grimaldi-Bensouda L.
        • Alpérovitch A.
        • Besson G.
        • Vial C.
        • Cuisset J.M.
        • Papeix C.
        • et al.
        Guillain–Barre syndrome, influenzalike illnesses, and influenza vaccination during seasons with and without circulating A/H1N1 viruses.
        Am J Epidemiol. 2011 Aug 1; 174: 326-335
        • Dieleman J.
        • Romio S.
        • Johansen K.
        • Weibel D.
        • Bonhoeffer J.
        • Sturkenboom M.
        • et al.
        Guillain–Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe.
        BMJ. 2011 Jul 12; 343: d3908
      1. Pandemic influenza: a priority for the neurological community.
        Lancet Neurol. 2009; 8: 869
        • Tan K.
        • Prerna A.
        • Leo Y.S.
        Surveillance of H1N1-related neurological complications.
        Lancet Neurol. 2010; 9: 142-143
        • Davis L.E.
        Neurologic and muscular complications of the 2009 influenza A (H1N1) pandemic.
        Curr Neurol Neurosci Rep. 2010 Nov; 10: 476-483
        • Centers for Disease Control and Prevention (CDC)
        Preliminary results: surveillance for Guillain–Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine—United States, 2009–2010.
        MMWR Morb Mortal Wkly Rep. Jun 4 2010; 59: 657-661
        • Kilander A.
        • Rykkvin R.
        • Dudman S.G.
        • Hungnes O.
        Observed association between the HA1 mutation D222G in the 2009 pandemic influenza A(H1N1) virus and severe clinical outcome, Norway 2009–2010.
        Euro Surveill. 2010; 15 ([pii=19498])
        • Mak G.C.
        • Au K.W.
        • Tai L.S.
        • Chuang K.C.
        • Cheng K.C.
        • Shiu T.C.
        • et al.
        Association of D222G substitution in haemagglutinin of 2009 pandemic influenza A (H1N1) with severe disease.
        Euro Surveill. 2010; 15 ([pii=19534])
        • Miller R.S.
        • MacLean A.R.
        • Gunson R.N.
        • Carman W.F.
        Occurrence of hemagglutinin mutation D222G in pandemic influenza A(H1N1) infected patients in the West of Scotland, United Kingdom, 2009–10.
        Euro Surveill. 2010; 15 ([pii=19546])
        • Baldanti F.
        • Campanini G.
        • Piralla A.
        • Rovida F.
        • Braschi A.
        • Mojoli F.
        • et al.
        Severe outcome of influenza A/H1N1/09v infection associated with 222G/N polymorphisms in the haemagglutinin: a multicentre study.
        Clin Microbiol Infect. 2011 Aug; 17: 1166-1179
        • Van Doorn P.A.
        • Ruts L.
        • Jacobs B.C.
        Clinical features, pathogenesis, and treatment of Guillain–Barré syndrome.
        Lancet Neurol. 2008 Oct; 7: 939-950